Novo Nordisk and Eli Lilly are expected to bring GLP-1 pills to market in the ne...
The company said it has adopted 23 ongoing "action plans" to track and implement...
Dealmakers expected a flood of M&A to take place in 2025 following the election ...
The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which i...
Trump’s pot executive order follows a yearlong industry push blending lobbying, ...
Club holding Lilly stock slumped 1% Tuesday while Novo Nordisk shares jumped nea...
The FDA on Monday approved the first-ever GLP-1 pill for weight loss from the Da...
